PEDIATRICS Vol. 65 No. 5 May 1980, pp. 989-994
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miller, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miller, J. J., III

Prolonged Use of Large Intravenous Steroid Pulses in the Rheumatic Diseases of Children

John J. Miller III MD, PhD1

1 Children's Hospital at Stanford, Department of Pediatrics, Stanford University School of Medicine, Stanford, California

Nineteen children with rheumatic diseases refractory to standard treatment were given repeated large "pulses" of corticosteroid therapy. The pulses consisted of four repeated doses of 500 mg of hydrocortisone given intravenously over 20 to 30 minutes at six-hour intervals or of single intravenous injections of 30 mg/kg of methylprednisolone. All patients had temporary relief of signs or symptoms of inflammation. Complications were mild and only one child was removed from therapy because of a complication. Two children were judged to be treatment failures. Five patients have been weaned from all steroid treatment, and eight have required continued pulses at one- or two-week intervals as outpatients to maintain control. All of these have been able to reduce oral prednisone doses. Effects of the two forms of pulse appear similar. However, two children responded to the series of injections of hydrocortisone but not to single doses of methylprednisolone. Pulses have been given for periods up to three years without evident toxicity. Further work to define doses, schedules, and optimal drug is needed since this approach to steroid use appears effective and relatively nontoxic.

Submitted on July 23, 1979
Accepted on August 20, 1979




This article has been cited by other articles:


Home page
 PediatricsHome page
J. D. Akikusa, B. M. Feldman, G. J. Gross, E. D. Silverman, and R. Schneider
Sinus Bradycardia After Intravenous Pulse Methylprednisolone
Pediatrics, March 1, 2007; 119(3): e778 - e782.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
P Defresne, L Meyer, M Tardieu, E Scalais, C Nuttin, B De Bont, G Loftus, P Landrieu, H Kadhim, and G Sebire
Efficacy of high dose steroid therapy in children with severe acute transverse myelitis
J. Neurol. Neurosurg. Psychiatry, August 1, 2001; 71(2): 272 - 274.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. C. Bernini, Z. R. Rogers, E. S. Sandler, J. S. Reisch, C. T. Quinn, and G. R. Buchanan
Beneficial Effect of Intravenous Dexamethasone in Children With Mild to Moderately Severe Acute Chest Syndrome Complicating Sickle Cell Disease
Blood, November 1, 1998; 92(9): 3082 - 3089.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
G. Sébire, H. Hollenberg, L. Meyer, G. Huault, P. Landrieu, and M. Tardieu
High dose methylprednisolone in severe acute transverse myelopathy
Arch. Dis. Child., February 1, 1997; 76(2): 167 - 168.
[Abstract] [Full Text]

Home page
 NEJMHome page
T. C. Griffin, D. McIntire, and G. R. Buchanan
High-Dose Intravenous Methylprednisolone Therapy for Pain in Children and Adolescents with Sickle Cell Disease
N. Engl. J. Med., March 17, 1994; 330(11): 733 - 737.
[Abstract] [Full Text]